Skip Navigation
Return to All Schools

Clayton Professorship in Oncology

School of Medicine

Established in 1993 by the Clayton Fund and by Benjamin Baker and his family

ClaytonWilliamWILLIAM L. CLAYTON, university trustee emeritus and a former member of the SAIS Advisory Council, was a leader in business and international affairs. He served for many years as president of Anderson, Clayton and Company, a Texas-based cotton trading company. In addition, Mr. Clayton served as the first American under secretary of state for economic affairs, during the Franklin D. Roosevelt administration. In 1963, when Mr. Clayton was in his eighties, President John F. Kennedy asked him to work on the national export expansion program and nuclear test ban treaty. The Clayton family is one of Johns Hopkins Medicine’s most generous benefactors. In 1947, Mr. Clayton, along with his wife, SUSAN VAUGHAN CLAYTON, established at Hopkins the Clayton Fund for Medical Research. In 1961, he established the William L. Clayton Professorship in International Economics at SAIS.

BakerBenjaminBeginning in 1984, the income was redirected to support colon cancer initiatives, reflecting the interests of the Claytons’ son-in-law, distinguished physician BENJAMIN BAKER, Med 1927. Gifts from Dr. Baker and his late wife, JULIA C. BAKER, and their family, along with a portion of the Clayton Fund, created the Clayton Professorship in Oncology. Colleagues called Dr. Baker a Renaissance physician and considered him to be a master diagnostician. An internist in private practice, he taught clinical medicine and physical diagnosis at Hopkins with the rank of professor. His early research focused on heart disease. Dr. Baker later turned his attention to pioneering work in colon cancer, establishing the Hopkins Bowel Tumor Working Group. In 1974, he was awarded an honorary degree by the university. In 1998, his family and friends established the Benjamin Baker Scholars program to assist young physician-scientists at Hopkins. Dr. Baker died in 2003 at the age of 101.

Held by Bert Vogelstein

VogelsteinBertBERT VOGELSTEIN, the Clayton Professor of Oncology and a Howard Hughes Investigator, was the first to elucidate the molecular basis of a common human cancer. Dr. Bert Vogelstein attended the University of Pennsylvania, where he graduated with distinction in mathematics. He obtained his medical degree at the Johns Hopkins University School of Medicine and performed his residency in pediatrics at the Johns Hopkins Hospital. Following his clinical training, Dr. Vogelstein completed a post-doctoral fellowship at the National Cancer Institute, focusing on the development of new approaches to study human cancers. He is currently the Co-Director of the Ludwig Center for Cancer Genetics & Therapeutics at the Johns Hopkins Kimmel Cancer Center, a Lustgarten Foundation Distinguished Scholar, and an Investigator of the Howard Hughes Medical Institute.

Dr. Vogelstein’s current research focuses on the genetic basis of human cancers and the use of this knowledge to improve diagnosis and management of patients with these diseases. He is a member of the American Academy of Arts & Sciences, the National Academy of Sciences, the American Philosophical Society, the National Academy of Medicine and the European Molecular Biology Organization (EMBO). His advisory roles have included Chairmanships of the National Research Council Committee on the Biological and Biomedical Applications of Stem Cell Research and the Board of Scientific Counselors of the National Human Genome Research Institute.